BBT wins UPC #HiloTesis competition

May 24, 2022

David Piñera and Miguel Mateu, both BBT doctoral students, get 1st and 2nd place in the #HiloTesis competition at the UPC. Piñera will represent our university in the state final of the competition, organized by Red de Divulgación y Cultura Científica (RedDivulga) of the Comisión Sectorial de I+D+i by the Conferencia de Rectores de les Universidades Españolas (CRUE).

One week ago, Universitat Politècnica de Catalunya · BarcelonaTech (UPC) selected the three best Twitter threads for the second edition of the #HiloTesis science dissemination competition, promoted at the UPC by its Doctoral School.

The initiative, convened by Crue Universidades Españolas, in collaboration with Red de Divulgación y Cultura Científica (RedDivulga) of the Crue – I + D + i Sectorial, is aimed at PhD students and recent PhD students who must explain, in a maximum of 20 tweets linked in a thread, the research they develop.

The 1st winner, and representative of the UPC in the state final of the competition, was David Piñera. Piñera is a student of the doctoral program in Biomedical Engineering and is developing his thesis in "Coatings of double-acting biomaterials with antibacterial properties and tissue integration", under the direction of Prof. José María Manero and Dr. Judit Buxadera. In his #hilotesis, David details, in a close and understandable tone, his research, focused on analyzing the feasibility of using silver in bone implants, for its antibacterial properties.

2nd place went to student Miguel Mateu, who is part of the ERC APACHE project. He is also a student of the doctoral program in Biomedical Engineering, and is carrying out his doctoral dissertation (which will be presented in a month) on the "Evaluation of the biological effects of atmospheric plasmas on bone cancer", under the direction of Dr. Cristina Canal and Dr. Juan Tornín. Miguel explained in his #hilotesis how he investigates whether it is possible to treat bone tumors with the use of low-temperature atmospheric plasmas and eliminate the carcinogenic stem cells present in this type of tumor.